Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face

Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face

Background. For large basal cell carcinomas (BCCs) of the head and neck, definitive surgery often requires extensive resection and reconstruction that may result in prolonged recovery and limited cosmesis. Vismodegib, a small-molecule inhibitor of the hedgehog pathway, is approved for advanced and m...

Full description

Saved in:
Bibliographic Details
Main Authors: Alec M. Block, Fiori Alite, Aidnag Z. Diaz, Richard W. Borrowdale, Joseph I. Clark, Mehee Choi
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2015/827608
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items